Operose Advisors’s Globus Medical GMED Stock Holding History

Operose Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-473	Closed	-$23.5K	–	657
2023 Q3	$23.5K	Buy	+473	New	+$26.4K	0.01%	447

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Operose Advisors's GMED Position: Q4 2023 in Review

Operose Advisors sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 473 shares — an estimated $23.5K sold.

Operose Advisors first reported a position in GMED in Q3 2023 and held it in 1 quarter. The position peaked at $23.5K in Q3 2023. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

Operose Advisors reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 473 Globus Medical shares in Q4 2023, an estimated $23.5K.
Operose Advisors first reported a position in Globus Medical in Q3 2023 and held it in 1 quarter.
Operose Advisors's Globus Medical position peaked at $23.5K in Q3 2023.
408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.